Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 130,189 | 52,880 | 0 | 0 | N/A |
| Other current assets | 0 | 2,378 | 0 | 0 | 0 |
| TOTAL | $131,271 | $55,597 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,767 | 2,782 | N/A | N/A | N/A |
| Other Non-Current Assets | 55 | 104 | 0 | 0 | 0 |
| TOTAL | $2,822 | $2,886 | $N/A | $N/A | $N/A |
| Total Assets | $134,093 | $58,484 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,271 | 2,215 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 2,584 | 2,645 | 0 | 0 | 0 |
| Accrued Expenses | 3,734 | 3,590 | 0 | 0 | N/A |
| TOTAL | $8,590 | $8,450 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,025 | 3,686 | 0 | 0 | N/A |
| Other Non-Current Liabilities | 0 | 3,726 | 0 | 0 | 0 |
| TOTAL | $3,025 | $7,412 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,615 | $15,862 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,441 | 1,441 | N/A | N/A | N/A |
| Common Shares | 10 | 1 | 0 | 0 | N/A |
| Retained earnings | -62,254 | -54,196 | 0 | 0 | N/A |
| Other shareholders' equity | 0 | 93,265 | 0 | 0 | 0 |
| TOTAL | $122,478 | $42,621 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $134,093 | $58,484 | $0 | $0 | $0 |